Patient Characteristics
toxicity
Of 718 patients enrolled onto GAP70+, 706 (98.3%) provided PRO-CTCAEs at baseline. Of 706 patients, 83 (11.8%) patients provided PRO-CTCAE data only at baseline and could not be included in the analyses of symptomatic toxicity. Of these 83 patients, 39 (47.0%) died within 4-6 weeks, six (7.2%) withdrew from the study, and 38 (45.8%) declined or were not further able to complete PRO measures (Fig Patients Characteristics at Initiation of Current Regimen